# EDGAR Filing Document

**Accession Number:** 0001861657
**File Stem:** 0001641172-25-026358
**Filing Date:** 2025-9
**Character Count:** 2069
**Document Hash:** fe3f78f7705ccbe84415f3f3f1f03687
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-026358.hdr.sgml**: 20251125

**ACCESSION NUMBER**: 0001641172-25-026358

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250903

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tharimmune, Inc.
- **CENTRAL INDEX KEY:** 0001861657
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 842642541
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1200 ROUTE 22 EAST
- **CITY:** BRIDGEWATER
- **STATE:** NJ
- **ZIP:** 08807
- **BUSINESS PHONE:** 302-743-2995

**MAIL ADDRESS:**
- **STREET 1:** 34 SHREWSBURY AVE
- **STREET 2:** SUITE 1C
- **CITY:** RED BANK
- **STATE:** NJ
- **ZIP:** 07701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Tharimmune, Inc
- **DATE OF NAME CHANGE:** 20230925

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hillstream BioPharma Inc.
- **DATE OF NAME CHANGE:** 20210511

**Tharimmune, Inc.**

**34 Shrewsbury Avenue**

**Red Bank, NJ 07701**

September 3, 2025

<u>VIA EDGAR</u>

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Re: Tharimmune, Inc. <br> Registration Statement on Form S-3, File No. 333-289869 Filed August 26, 2025

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Requested Date: September 4, 2025

Requested Time: 5:00 p.m., Eastern Time

Ladies and Gentlemen:

Tharimmune, Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3, as amended (File No. 333-289869), be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it is declared and becomes effective at 5:00 p.m. Eastern time on Thursday, September 4, 2025, or as soon as practicable thereafter.

---

| |
|:---|
| Sincerely yours, |
| Tharimmune, Inc. |
| */s/ Sireesh Appajosyula* |
| Sireesh Appajosyula |
| Chief Executive Officer |

---